The trademark application LUMIERA HEALTH INNOVATION was filed by Tetra Bio-Pharma Inc., a corporation established under the laws of Canada (the "Applicant"). The application was published for oppositions on June 11, 2020, and it was registered by office on September 21, 2020 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations for the treatment of pain and inflammation
Pharmaceutical preparations for the treatment of ocular pain and inflammation, uveitis and dried eyes in humans
Pharmaceutical preparations for the treatment of ocular pain and inflammation, uveitis and dried eyes in pets
Pharmaceutical preparations for the treatment of cold sores
Pharmaceutical preparations for the treatment of interstitial cystitis in humans.